Idexx Laboratories reported $1.5B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Accuray USD 292.39M 11.22M Dec/2025
Align Technology USD 2.73B 63.03M Sep/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Dentsply International USD 1.98B 50M Sep/2026
Dexcom USD 3.92B 170.6M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Fujifilm JPY 1.7T 23.16B Sep/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Henry Schein USD 4.78B 176M Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
Neogen USD 582.5M 22.1M Jun/2026
Orthofix International USD 430.79M 15.34M Sep/2026
Phibro Animal Health USD 945.17M 9.67M Sep/2026
ResMed USD 3.51B 815.82M Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Steris USD 2.48B 33.4M Sep/2026
Tandem Diabetes Care USD 820.72M 16.08M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Zoetis USD 6.29B 63M Sep/2026